Effect Of DAAs For Treatment Of HCV On Normal Kidney
Status:
Unknown status
Trial end date:
2018-10-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the effect of different direct acting antiviral drugs
used for treatment of chronic HCV infected patients on normal kidney.